Replies to post #3267 on Revance Therapeutics Inc (RVNC)

[DewDiligence]

Hope an analyst makes a request for the botox 20 and jeuveau [20] median duration data on monday. If not, then the analysts were handpicked is my impression.

I was thinking the same thing. EOLS will need to raise more capital at some point, so they have pull with some of the IBs.

[DewDiligence]

EOLS CC slides for double-dose Jeuveau—see_comments_below:

https://s29.q4cdn.com/603291515/files/doc_presentation/2023/2023.01.30-analyst-call-extra-strength-phase-ii-study-interim-results-website.pdf

The slide set does not show duration curves for the 20U-Jeuveau and 20U-Botox control arms! The reason for this omission is probably that the duration metrics in the control arms were similar to—or even indistinguishable from—those for the 40U (double-dose) Jeuveau arm.

[DewDiligence]

Hope an analyst makes a request for the botox 20 and jeauvea median duration data on Monday.

One analysts just asked the above question, but EOLS’ CMO danced around the answer in a way that can only be described as insulting to investors’ intelligence.